journal article·2023-06

Synthesis of NIR‐II Fluorescent Hybrid Ag2S/ZnPc Nanoparticles for in vitro Photodynamic Therapy

Yuxin Bao, Xi Wu, Bingyang Bo, Jinglei Qin, Yafei Zhang, Xiaojia Wu, Xiang Li, Yiquan Wang, Hongshang Peng

ChemNanoMat· Volume 9· Issue 6
Publisher page

Abstract

Abstract Fluorescence imaging‐guided photodynamic therapy (PDT), particularly near infrared II (NIR‐II) fluorescence featuring deep penetration depth, can greatly improve the treatment outcomes with precise administration. In this work, a reprecipitation‐encapsulation method was used to co‐load NIR‐II fluorescent Ag2S quantum dots (QDs) and photosensitizer zinc phthalocyanine (ZnPc) into single nanoparticles (NPs), i. e., Ag2S/ZnPc NPs. Moreover, the resultant NPs were coated by a poly‐L‐lysine (PLL) layer, which endowed the initial hydrophobic Ag2S QDs and ZnPc with good biocompatibility. Ag2S/ZnPc NPs exhibited a hydrodynamic diameter of ∼70 nm, strong NIR‐II fluorescence peaking at 1052 nm, efficient cellular uptaken, and high singlet oxygen generation. Taking advantage of Ag2S/ZnPc NPs, efficient phototherapeutic efficacy was achieved on HeLa cells upon the irradiation of 660 nm light, and a deep optical tissue penetration depth of 1.4 mm was obtained under 808 nm excitation. These results suggested that the facilely prepared Ag2S/ZnPc NPs are very promising for NIR‐II fluorescence imaging‐guided in vivo PDT.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Science Minzu University of China Beijing 100081 China

Key Laboratory of Luminescence and Optical Information Ministry of Education Institute of Optoelectronic Technology Beijing Jiaotong University Beijing 100044 China

Funding

National Natural Science Foundation of China

References (46)

Show source-provided references
1. 10.1021/cr400532z10.1021/cr400532z ↗
2. 10.1038/s12276-021-00599-710.1038/s12276-021-00599-7 ↗
3. 10.1002/advs.20210258710.1002/advs.202102587 ↗
4. 10.1021/acs.jmedchem.7b0068210.1021/acs.jmedchem.7b00682 ↗
5. 10.1039/C6DT01929C10.1039/C6DT01929C ↗
6. 10.1039/c4dt00197d10.1039/c4dt00197d ↗
7. 10.1016/j.pdpdt.2018.06.00310.1016/j.pdpdt.2018.06.003 ↗
8. 10.1016/j.materresbull.2019.02.02010.1016/j.materresbull.2019.02.020 ↗
9.
10. 10.1002/ppsc.20130018910.1002/ppsc.201300189 ↗
11. 10.1016/j.jconrel.2021.09.02410.1016/j.jconrel.2021.09.024 ↗
12.
13. 10.3390/nano1105129310.3390/nano11051293 ↗
14. Liu Y. · Adv. Sci. · 2022 · 1010.1002/advs.202203669 ↗
15. 10.1562/2006-04-14-IR-87410.1562/2006-04-14-IR-874 ↗
16.
17. 10.1039/C9NR05733A10.1039/C9NR05733A ↗
18. 10.1002/anie.20110836010.1002/anie.201108360 ↗
19. 10.1002/ange.20110836010.1002/ange.201108360 ↗
20.
21. 10.1021/acs.analchem.9b0415610.1021/acs.analchem.9b04156 ↗
22. 10.1038/nm.299510.1038/nm.2995 ↗
23. 10.1038/nmat447610.1038/nmat4476 ↗
24. 10.1038/nphoton.2014.16610.1038/nphoton.2014.166 ↗
25. 10.1002/ange.20150747310.1002/ange.201507473 ↗
26. 10.1002/anie.20150747310.1002/anie.201507473 ↗
27. 10.1002/anie.20140742010.1002/anie.201407420 ↗
28. 10.1002/ange.20140742010.1002/ange.201407420 ↗
29. 10.1002/adfm.20190056610.1002/adfm.201900566 ↗
30.
31. 10.1002/hc.2146710.1002/hc.21467 ↗
32. 10.1021/acs.bioconjchem.9b0008810.1021/acs.bioconjchem.9b00088 ↗
33. 10.1016/j.nantod.2021.10112010.1016/j.nantod.2021.101120 ↗
34.
35. 10.1186/s12951-020-0572-110.1186/s12951-020-0572-1 ↗
36. 10.1039/C9SC02674F10.1039/C9SC02674F ↗
37.
38. 10.1039/C4RA06098A10.1039/C4RA06098A ↗
39. Sun J. · Acta Pharm. Sin. · 2020 · 12 · 1699
40. 10.1002/etc.562017041110.1002/etc.5620170411 ↗
41. 10.1002/anie.20200094710.1002/anie.202000947 ↗
42. 10.1002/ange.20200094710.1002/ange.202000947 ↗
43. 10.1002/adom.20210023310.1002/adom.202100233 ↗
44. 10.1039/C6TB00307A10.1039/C6TB00307A ↗
45. 10.1021/jp501266d10.1021/jp501266d ↗
46. 10.1002/smll.20200100310.1002/smll.202001003 ↗